Search
Search Results
##search.searchResults.foundPlural##
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2288PDF: 752HTML: 2144Untitled: 247Untitled: 170Untitled: 201Untitled: 174Untitled: 192Untitled: 200Untitled: 205 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2649PDF: 977HTML: 581 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1468PDF: 852HTML: 8672Fig 3 Savini: 200Fig 2 Savini: 206Fig 1 Savini Chest TC: 205Author letter to referees: 210 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1855PDF: 611HTML: 349 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2852PDF: 1012HTML: 4724 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2064PDF: 777HTML: 723Table1: patient's characteristics: 175Table 2: profile of each patient: 197 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1592PDF: 1143HTML: 262 -
Osteolytic bone lesions – A rare presentation of AML M6.
2053PDF: 1162HTML: 7990Untitled: 218 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2334PDF: 919HTML: 2014Fig 1 Rossi: 220 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3037PDF: 898HTML: 6611Untitled: 262Untitled: 218Untitled: 234Untitled: 247 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1523PDF: 1370HTML: 112 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3315PDF: 1379HTML: 4151 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2928PDF: 1052HTML: 5639 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4406PDF: 1426HTML: 2187 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1441PDF: 1297HTML: 515 -
Severe eosinophilia in a case of giardiasis
1115PDF: 1608HTML: 451 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4950PDF: 2922HTML: 2343 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1265PDF: 771Html: 113 -
-
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1807PDF: 1233HTML: 332 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2181PDF: 599HTML: 365







